Stockreport

C4 Therapeutics inks new deal with Roche for degrader-antibody conjugates [Seeking Alpha]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Roche ( RHHBY RHHBF ) to develop a new class of cancer drugs called degrader-antibody conjugates (DACs). Under the partnership, the companies will combine antibody-dru [Read more]